Form 4: Director Jean-Jacques Bienaime Buys Immunome Stock

Director Jean-Jacques Bienaime acquired 5,000 shares of Immunome Inc. common stock for an average price of $20.70 per share.

Summary

• Jean-Jacques Bienaime, a Director at Immunome Inc., purchased 5,000 shares of common stock on May 15, 2026.
• The average purchase price was $20.70 per share, with transactions occurring within a range of $20.645 to $20.72.
• Following this transaction, Bienaime beneficially owns 43,415 shares of common stock directly.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing due to a director increasing their direct stake, which can imply confidence, but it does not represent a significant strategic or financial development for the company.

Positives

• Director's increased direct ownership in the company, signaling confidence.
• Acquisition of shares at a price point that may be considered attractive by management.

Future Outlook

No forward-looking statements or guidance are present in this filing.

Industry Context

StockSavvy.ai notes that insider buying, particularly by directors, can be a positive signal to the market, suggesting a belief in the company's future prospects. This transaction by a director of Immunome Inc. falls within typical insider activity patterns.

Stakeholder Impact

• Shareholders may view this as a positive signal of insider confidence in the company's value.
• The company's management team may be encouraged by the director's investment.

Key Dates

Keywords

Immunome Inc., IMNM, Form 4, Insider Trading, Director Transaction, Common Stock, Share Acquisition